Biotechnology Company Regeneron to Buy 23andMe for $256 million

inc.com/associated-press/regeneron-to-buy-23andme-for-256-million/91190870

A look at why the publicly traded pharmaceutical giant is snapping the genetic-testing company out of bankruptcy.

This story appeared on inc.com, 2025-05-19 15:12:33.
The Entire Business World on a Single Page. Free to Use →